Kite, HiFiBiO Therapeutics partner to discover novel targets and antibodies against AML

This article was originally published here

Through this collaboration, HiFiBiO will use its proprietary technology platforms to identify novel AML targets and anti-AML specific antibodies for Kite’s use in cell therapies. “Kite is committed

The post Kite, HiFiBiO Therapeutics partner to discover novel targets and antibodies against AML appeared first on Pharmaceutical Business review.